Skip to main content

Table 2 Demographic and clinical characteristics of study participants

From: Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study

  PD (n = 65) Control (n = 27)
Male/female (n) 48/17 19/8
Age (years) 66.2 ± 9.4 68.7 ± 9.6
Education (years) 12.8 ± 2.9 13.4 ± 2.9
MMSE 28.0 ± 2.7 29.0 ± 1.1
MoCA 23.9 ± 5.1 27.0 ± 1.9
Symptom duration (years) 6.3 ± 5.7  
range 0.5-30  
UPDRS part III 33.7 ± 16.3 -
Modified H & Y stage (median) 2.5  
range 1–4  
Cognitive status (n)   
    Unimpaired 41 27
    MCI 14  
    Dementia 10  
PD Medication Status (n)   
  No medication 24  
  On Medication 41  
    LED (mg/day) 572.4 ± 339.5  
  1. Values are expressed as mean ± standard deviation, unless otherwise stated. MMSE Mini Mental State Examination, MoCA Montreal Cognitive Assessment, UPDRS Unified Parkinson’s Disease Rating Scale, H & Y Hoehn and Yahr scale, MCI mild cognitive impairment, LED levodopa equivalent dose.